ANTI-SYNTHETASE SYNDROME
Clinical trials for ANTI-SYNTHETASE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ANTI-SYNTHETASE SYNDROME trials appear
Sign up with your email to follow new studies for ANTI-SYNTHETASE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CAR T-Cell therapy takes on rare muscle disease
Disease control Recruiting nowThis study tests a new treatment called CABA-201 for people with active idiopathic inflammatory myopathy, a group of rare diseases that cause muscle inflammation and weakness. The treatment uses a patient's own immune cells, modified to target and destroy faulty B cells. The goal…
Matched conditions: ANTI-SYNTHETASE SYNDROME
Phase: PHASE2, PHASE3 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Patients take the lead: rare disease research gets a new voice
Knowledge-focused Recruiting nowThis study asks people living with rare myositis diseases (and their caregivers) what research questions matter most to them. Researchers will collect ideas through online surveys and forums. The goal is to create a patient-driven list of priorities to guide future studies and fu…
Matched conditions: ANTI-SYNTHETASE SYNDROME
Sponsor: Myositis International Health & Research Collaborative Alliance Foundation • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC